Agilent Technologies Inc (A) : Robecosam Ag reduced its stake in Agilent Technologies Inc by 2.9% during the most recent quarter end. The investment management company now holds a total of 768,225 shares of Agilent Technologies Inc which is valued at $36,982,352 after selling 22,926 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Agilent Technologies Inc makes up approximately 3.17% of Robecosam Ag’s portfolio.
Other Hedge Funds, Including , 1832 Asset Management reduced its stake in A by selling 415 shares or 30.51% in the most recent quarter. The Hedge Fund company now holds 945 shares of A which is valued at $45,492. Dynamic Technology Lab Private Ltd added A to its portfolio by purchasing 9,413 company shares during the most recent quarter which is valued at $453,142. Agilent Technologies Inc makes up approx 0.12% of Dynamic Technology Lab Private Ltd’s portfolio.Dimensional Fund Advisors Lp boosted its stake in A in the latest quarter, The investment management firm added 4,165 additional shares and now holds a total of 1,093,023 shares of Agilent Technologies Inc which is valued at $51,623,476. Agilent Technologies Inc makes up approx 0.03% of Dimensional Fund Advisors Lp’s portfolio.Mutual Of America Capital Management boosted its stake in A in the latest quarter, The investment management firm added 6,072 additional shares and now holds a total of 56,089 shares of Agilent Technologies Inc which is valued at $2,641,231. Agilent Technologies Inc makes up approx 0.05% of Mutual Of America Capital Management’s portfolio.Ibm Retirement Fund reduced its stake in A by selling 599 shares or 1.53% in the most recent quarter. The Hedge Fund company now holds 38,545 shares of A which is valued at $1,795,426. Agilent Technologies Inc makes up approx 0.06% of Ibm Retirement Fund’s portfolio.
Agilent Technologies Inc opened for trading at $47.45 and hit $47.89 on the upside on Monday, eventually ending the session at $47.62, with a gain of 0.63% or 0.3 points. The heightened volatility saw the trading volume jump to 13,32,975 shares. Company has a market cap of $15,501 M.
On the company’s financial health, Agilent Technologies Inc reported $0.49 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 17, 2016. Analyst had a consensus of $0.47. The company had revenue of $1044.00 million for the quarter, compared to analysts expectations of $1046.16 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.44 EPS.
Many Wall Street Analysts have commented on Agilent Technologies Inc. Company shares were Reiterated by Jefferies on May 17, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $46 .Company shares were Reiterated by Barclays on May 17, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 45 from a previous price target of $42 .
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.